Abbott Laboratories

Abbott is in the business of creating breakthrough products in medical devices, nutrition, diagnostics, and branded generic pharmaceuticals. Some of the company’s best-known healthcare brands include products you’re probably really familiar with like Pedialyte, Ensure, Similac, and Glucerna. Abbott is also a leader in diagnostics and a conglomerate you’ll want to keep your eye on.

$129.69
(as of Mar 13, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Abbott Laboratories

Stock Price
$129.70
Ticker Symbol
ABT
Exchange
NYSE

Industry Information for Abbott Laboratories

Sector
Healthcare
Industry
Medical Devices

Company Description for Abbott Laboratories

Country
USA
Full Time Employees
114,000

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Fundamentals for Abbott Laboratories

Market Capitalization
$225,947,205,632
EBITDA
$10,714,000,384
Dividends per Share
$2.24
P/E Ratio
17.05
Forward P/E Ratio
25.77
Earnings per Share
$7.64
Earnings per Share Estimate Next Year
$5.67
Profit Margin
31.95%
Shares Outstanding
1,734,320,000
Percent Owned by Insiders
0.54%
Percent Owned by Institutions
79.37%
52-Week High
$141.23
52-Week Low
$98.72

Technical Indicators for Abbott Laboratories

50-Day Moving Average
$126.23
200-Day Moving Average
$114.96
RSI
44.86
2.92

Analyst Ratings for Abbott Laboratories

Strong Buy
13
Buy
8
Hold
6
Sell
0
Strong Sell
0

News About Abbott Laboratories

Mar 11, 2025, 9:00 AM EST
Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. See more.
Mar 11, 2025, 5:03 AM EST
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks See more.
Mar 10, 2025, 5:03 AM EST
3 Reasons to Avoid ABT and 1 Stock to Buy Instead See more.
Mar 8, 2025, 6:00 AM EST
Key Insights See more.
Mar 7, 2025, 5:28 AM EST
ABT is a global healthcare company with that offers cardiovascular and diabetes devices, nutritional products, diagnostic equipment, and branded generic drugs. See more.